Condition
Recurrent Respiratory Papillomatosis clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Recurrent Respiratory Papillomatosis clinical trials that are recruiting, in United States. By phase: Phase 1 (1), Phase 4 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest Recurrent Respiratory Papillomatosis clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Autologous dendritic cell vaccine for recurrent respiratory papillomatosis | Phase 1 | Scottsdale, Arizona | Recruiting | Jan 5, 2026 |
| Treatment of Recurrent Respiratory Papillomatosis with PRGN-2012 | Phase 4 | Atlanta, Georgia and 2 other locations | Recruiting | Aug 5, 2024 |
| Understanding the biology of Pulmonary Recurrent Respiratory Papillomatosis | — | New Haven, Connecticut | Recruiting | May 14, 2024 |
| Pembrolizumab plus lenvatinib for HPV-related recurrent respiratory papillomatosis with lung involvement | Phase 2 | New Haven, Connecticut | Recruiting | Nov 27, 2020 |
| Registry for patients with rare diseases | — | Sioux Falls, South Dakota | Recruiting | Feb 15, 2013 |
All recruiting trials (5)
-
Autologous dendritic cell vaccine for recurrent respiratory papillomatosis
This test tries a vaccine made from your own dendritic cells loaded with HPV6 peptides to see if it is safe and stimulates the immune system in people with HPV6-positive recurrent respiratory papillomatosis.
-
Treatment of Recurrent Respiratory Papillomatosis with PRGN-2012
This study is testing a new treatment called PRGN-2012 in adults with recurrent respiratory papillomatosis to see if it helps reduce their symptoms after multiple surgeries.
-
Understanding the biology of Pulmonary Recurrent Respiratory Papillomatosis
This study is collecting tissue samples from patients with Pulmonary Recurrent Respiratory Papillomatosis to better understand the disease and find new treatments.
-
Pembrolizumab plus lenvatinib for HPV-related recurrent respiratory papillomatosis with lung involvement
This research will try pembrolizumab together with lenvatinib in adults who have HPV-associated recurrent respiratory papillomatosis that involves the lungs.
-
Registry for patients with rare diseases
This study is creating a central registry for people with rare diseases to help connect them with researchers and improve treatments.
Related topics
Quick answers
How many Recurrent Respiratory Papillomatosis clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 4: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.